Related Experiment Videos

The NCI Drug Information System. 5. DIS Biology Module

M T Zehnacker, R H Brennan, G W Milne

Journal of Chemical Information and Computer Sciences

|November 1, 1986

Abstract:

The NCI drug screening program tests over 10,000 chemicals per year for activity against cancer. The associated Drug Information System (DIS) captures all the raw testing data and provides for its validation. The large quantity of numeric data gathered during testing is maintained within the DIS in a database that is interactively searchable and automatically updated at regular intervals.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

The transition from a pharmacophore-guided approach to a receptor-guided approach in the design of potent protein kinase C ligands.

Pharmacology & therapeutics·1999

Monocarboxylic-based phosphotyrosyl mimetics in the design of GRB2 SH2 domain inhibitors.

Bioorganic & medicinal chemistry letters·1999

Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.

Journal of medicinal chemistry·1999

Identification of HIV-1 integrase inhibitors based on a four-point pharmacophore.

Antiviral chemistry & chemotherapy·1998

Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.

Journal of medicinal chemistry·1998

Identification of a nucleotide binding site in HIV-1 integrase.

Proceedings of the National Academy of Sciences of the United States of America·1998

See all related articles